Beacon Capital Management LLC (Tennessee)’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6K | Hold |
15,000
| – | – | ﹤0.01% | 568 |
|
|
2025
Q1 | $6.77K | Hold |
15,000
| – | – | ﹤0.01% | 703 |
|
|
2024
Q4 | $7.54K | Hold |
15,000
| – | – | ﹤0.01% | 648 |
|
|
2024
Q3 | $13.6K | Hold |
15,000
| – | – | ﹤0.01% | 578 |
|
|
2024
Q2 | $15K | Hold |
15,000
| – | – | ﹤0.01% | 496 |
|
|
2024
Q1 | $22.2K | Hold |
15,000
| – | – | ﹤0.01% | 433 |
|
|
2023
Q4 | $17.7K | Buy |
+15,000
| New | +$17.7K | 0.01% | 408 |
|